Pitobrutinib / Pitobrutinib (pirtobrutinib) regular purchase channels and how to obtain it in pharmacies

Pitobrutinib/Pirtobrutinib (pirtobrutinib) is a new generation of non-covalent BTK inhibitors, mainly used to treat chronic lymphocytic leukemia, lymphoma and other B cell malignant tumors. In China, the drug has been marketed as an original drug and has been included in medical insurance, and the price is relatively high. At present, the common specifications in China are 100 mg 14 tablets and 4 tablets. Each box may be sold for more than 40,000 yuan, so patients need to make financial and treatment plans in advance when purchasing and using it.

In terms of domestic formal acquisition channels, pitubrutinib is mainly sold through large general hospitals, oncology hospitals and some approved pharmacies. Patients usually need to buy it with a doctor's prescription and use it under the guidance of a doctor to ensure the safety and efficacy of the medication. Hospital pharmacies usually provide detailed medication guidance, including dosage adjustments, medication precautions, and management of possible adverse reactions. Purchasing medicines without a prescription or through informal channels involves quality risks, and it is not recommended to purchase them online or from unauthorized merchants.

In overseas markets, the original drug pitubrutinib has been launched in Europe and the United States. Common specifications include 50mg 30 tablets and 100mg 60 tablets. Each box sells for nearly 100,000 yuan, which is very expensive. Overseas purchases usually need to go through local hospitals or regular pharmacies and comply with local prescription drug management regulations. At the same time, due to cross-border transportation, customs and regulatory restrictions, individuals importing drugs must strictly abide by relevant policies to avoid legal or usage risks.

In addition, generic versions of Pitobrutinib have been sold overseas. For example, the Laos pharmaceutical factory produces 50 mg 30 tablets, priced at more than 2,000 yuan per box (may change due to exchange rates and market fluctuations). The ingredients of these generic drugs are basically the same as those of the original ones, but it is still recommended to consult a doctor before use to confirm whether it is suitable for your own condition and dosage plan. In short, whether at home or abroad, the formal channels for obtaining pitubrutinib must rely on doctor's prescriptions and authorized pharmacies to ensure drug quality, safety and therapeutic effect.

Reference:https://en.wikipedia.org/wiki/Pirtobrutinib